Commercial Positioning
Integrated solutions to position your product for global success
Health Economics and Patient Outcomes
Delivering commercially relevant and scientifically rigorous evidence to elevate your product’s value proposition and optimise reimbursement potential.
Our integrated market access, pricing, communications and health economics experts provide strategic guidance and tactical solutions to demonstrate the value of your product and support brand success around the globe. We help pharma, device and biotechnology companies at every stage of development, from endpoint selection and PRO development, through clinical trials, to post-approval and scientific publication.
Integrated solutions to accelerate market access and drive product adoption.
- Patient Reported OutcomesIncorporating the patient's voice into drug and device development
- Market Research & AnalyticsDelivering research-driven payer, provider and patient insights
- Creative and Digital ServicesAn award-winning, in-house design agency to support brand success
- Publication ManagementPubsHub medical communications software designed with your team in mind
- Real World IntelligenceExpertise and technology to identify, generate and synthesize real world data
Patient Reported Outcomes
Incorporating the patient's voice into drug and device development
Market Research & Analytics
Delivering research-driven payer, provider and patient insights
Creative and Digital Services
An award-winning, in-house design agency to support brand success
Publication Management
PubsHub medical communications software designed with your team in mind
Real World Intelligence
Expertise and technology to identify, generate and synthesize real world data
Commercialisation and Outcomes Briefing
Read our latest briefing for industry insights and analysis on key issues and trendsInsights and thought leadership
Pharma marketing in the digital age
Social media and digital technology are providing new opportunities for pharma marketers to make a fundamental difference.
ICER's impact on payer decision making
In the US, ICER has emerged as a leading voice in evaluating the clinical and economic value of healthcare technologies. Read our third annual payer survey.
COVID-19 impact on HTA and reimbursement requirements
We look at how the pandemic could impact existing product pipelines and existing HEOR evidence planning and timetables.
The value of PRO data to US payers
With the increase in patient centricity, we surveyed US payers from MCOs, IDNs and PBMs to get their take on the value and use of patient reported outcome data.
Latest on pricing & market access
If you would like to receive our pricing and market access email updates please visit the ICON Preference Centre and select 'Pricing & Market Access' under the 'Value Based Development' sub heading.
Receive pricing and market access email updates